Louisiana 2011 Regular Session

Louisiana House Bill HB12 Latest Draft

Bill / Chaptered Version

                            ENROLLED
Page 1 of 3
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
ACT No. 420
Regular Session, 2011
HOUSE BILL NO. 12
BY REPRESENTATIVES TEMPLET, ANDERS, ARNOLD, AUBERT, AUSTI N
BADON, BOBBY BADON, BALDONE, BILLIOT, BROSSETT, HENRY BURNS,
TIM BURNS, BURRELL, CARTER, CHAMPAGNE, CHANDLER, CHANEY,
CONNICK, CORTEZ, CROMER, DANAHAY, DIXON, DOWNS, EDWARDS,
ELLINGTON, FANNIN, FOIL, GEYMANN, GISCLAIR, GREENE, GUINN,
HARDY, HARRISON, HAZEL, HENRY, HILL, HOFFMANN, HONORE,
HOWARD, HUTTER, KATZ, LABRUZZO, LAMBERT, LANDRY, LEBAS, LIGI ,
LITTLE, MCVEA, MONTOUCET, MORENO, MORRIS, PEARSON, PONTI,
POPE, PUGH, RICHARD, RICHARDSON, ROY, SCHRODER, SIMON, SMILEY,
JANE SMITH, ST. GERMAIN, TALBOT, THIBAUT, TUCKER, WHITE,
WILLIAMS, WILLMOTT, AND WOOTON AND SENATORS LAFLEUR, LONG,
MARTINY, MILLS, MORRISH, QUINN, SHAW, SMITH, AND THOMPSON
Prefiled pursuant to Article III, Section 2(A)(4)(b)(i) of the Constitution of Louisiana.
AN ACT1
To amend and reenact R.S. 40:964 (Schedule I)(E)(introductory paragraph), to enact R.S.2
40:964(Schedule I)(E)(8) and (9) and (F), and to repeal R.S. 40:964(Schedule3
I)(C)(32), relative to synthetic controlled dangerous substances; to add certain4
synthetic substances to Schedule I; and to provide for related matters.5
Be it enacted by the Legislature of Louisiana:6
Section 1. R.S. 40:964 (Schedule I)(E)(introductory paragraph) is hereby amended7
and reenacted and R.S. 40:964(Schedule I)(E)(8) and (9) and (F) are hereby enacted to read8
as follows: 9
ยง964.  Composition of schedules10
Schedules I, II, III, IV, and V shall, unless and until added to pursuant to R.S.11
40:962, consist of the following drugs or other substances, by whatever official12
name, common or usual name, chemical name, or brand name designated:13
SCHEDULE I14
*          *          *15
E. Stimulants.  Unless specifically excepted, 	or contained within a16
pharmaceutical product approved by the United States Federal Food and Drug17
Administration, or unless listed in another schedule, any material, compound,18 ENROLLEDHB NO. 12
Page 2 of 3
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
mixture, or preparation which contains any quantity of the following substances1
having a stimulant effect on the central nervous system including its salts, isomers,2
esters, or ethers and salts of isomers, esters, or ethers whenever the existence of such3
salts, isomers, esters, or ethers and salts of isomers, esters, or ethers is possible4
within the specific chemical designation:5
*          *          *6
(8) Naphthylpyrovalerone whether or not further substituted in the naphthyl7
ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents,8
whether or not further substituted in the naphthyl ring by one or more other univalent9
substituents or whether or not further substituted in the carbon chain at the 3, 4, or10
5 position with an alkyl substituent.11
(9) 2-amino-1-phenyl-1-propanone (cathinone) or variation in any of the12
following ways:13
(i) By substitution in the phenyl ring to any extent with alkyl, alkoxy,14
alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in15
the phenyl ring by one or more other univalent substituents.16
(ii)  By substitution at the 3-position with an alkyl substituent.17
(iii) By substitution at the nitrogen atom with alkyl, dialkyl, or benzyl18
groups, or by inclusion of the nitrogen atom in a cyclic structure.19
F. Synthetic cannabinoids.  Unless specifically excepted or unless listed in20
another schedule, any material, compound, mixture, or preparation, which contains21
any quantity of a synthetic cannabinoid found to be in any of the following chemical22
groups, or any of those groups which contain any synthetic cannabinoid salts,23
isomers, or salts of isomers, whenever the existence of such salts, isomers, or salts24
of isomers is possible within the specific chemical designation, including all25
synthetic cannabinoid chemical analogues in such groups:26
(1) Naphthoylindoles whether or not substituted in the indole ring to any27
extent or the naphthyl ring to any extent.28
(2) Naphthylmethylindoles whether or not substituted in the indole ring to29
any extent or the naphthyl ring to any extent.30 ENROLLEDHB NO. 12
Page 3 of 3
CODING: Words in struck through type are deletions from existing law; words underscored
are additions.
(3)  Naphthoylpyrroles whether or not substituted in the pyrrole ring to any1
extent or the naphthyl ring to any extent.2
(4) Naphthylmethylindenes whether or not substituted in the indene ring to3
any extent or the naphthyl ring to any extent.4
(5) Phenylacetylindoles whether or not substituted in the indole ring to any5
extent or the phenyl ring to any extent.6
(6)  Cyclohexylphenols whether or not substituted in the cyclohexyl ring to7
any extent or the phenyl ring to any extent.8
(7)  Dibenzopyrans whether or not substituted in the cyclohexyl ring to any9
extent or the phenyl ring to any extent.10
(8) Benzoylindoles whether or not substituted in the indole ring to any extent11
or the phenyl ring to any extent.12
*          *          *13
Section 2.  R.S. 40:964(Schedule I)(C)(32) is hereby repealed in its entirety.14
Section 3. This Act shall become effective on July 15, 2011;  if vetoed by the15
governor and subsequently approved by the legislature, this Act shall become effective on16
July 15, 2011, or on the day following such approval by the legislature, whichever is later.17
SPEAKER OF THE HOUSE OF REPRESENTATI VES
PRESIDENT OF THE SENATE
GOVERNOR OF THE STATE OF LOUISIANA
APPROVED: